nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR4—Signaling by GPCR—PIK3CA—melanoma	0.000419	0.000419	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CSF2—melanoma	0.000418	0.000418	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MDM2—melanoma	0.000417	0.000417	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SUFU—melanoma	0.000416	0.000416	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ERBB2—melanoma	0.000411	0.000411	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCR2—melanoma	0.000409	0.000409	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CXCL8—melanoma	0.000409	0.000409	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PIK3CB—melanoma	0.000406	0.000406	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RAC2—melanoma	0.000403	0.000403	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PRKCA—melanoma	0.000401	0.000401	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT3—melanoma	0.000399	0.000399	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	0.000398	0.000398	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—WNT5A—melanoma	0.000396	0.000396	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFC—melanoma	0.000396	0.000396	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CXCL8—melanoma	0.00039	0.00039	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EDN1—melanoma	0.000389	0.000389	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—BCL2L11—melanoma	0.000388	0.000388	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RHOB—melanoma	0.000388	0.000388	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—HRAS—melanoma	0.000387	0.000387	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CDKN1B—melanoma	0.000381	0.000381	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CSF2—melanoma	0.00038	0.00038	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—AKT1—melanoma	0.000376	0.000376	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HDAC6—melanoma	0.000373	0.000373	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CASP3—melanoma	0.000373	0.000373	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL2—melanoma	0.000372	0.000372	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—RAC1—melanoma	0.000372	0.000372	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—IL6—melanoma	0.000371	0.000371	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—EDN1—melanoma	0.00037	0.00037	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	0.000368	0.000368	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PRKCA—melanoma	0.000364	0.000364	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCND1—melanoma	0.000363	0.000363	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CSF2—melanoma	0.000361	0.000361	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CTNNB1—melanoma	0.00036	0.00036	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MAP2K2—melanoma	0.000356	0.000356	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCR2—melanoma	0.000354	0.000354	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CXCL8—melanoma	0.000353	0.000353	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MMP9—melanoma	0.000353	0.000353	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	0.000352	0.000352	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CDKN1A—melanoma	0.000351	0.000351	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PTEN—melanoma	0.00035	0.00035	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NFKB1—melanoma	0.000349	0.000349	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—F2R—melanoma	0.000348	0.000348	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RAC2—melanoma	0.000348	0.000348	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PRKCA—melanoma	0.000346	0.000346	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—WNT5A—melanoma	0.000343	0.000343	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFC—melanoma	0.000343	0.000343	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—AKT1—melanoma	0.000342	0.000342	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—RAC1—melanoma	0.000338	0.000338	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EDNRB—melanoma	0.000337	0.000337	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EDN1—melanoma	0.000336	0.000336	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CSF2—melanoma	0.000328	0.000328	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTK2B—melanoma	0.000327	0.000327	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—RAC1—melanoma	0.000321	0.000321	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GAB2—melanoma	0.000318	0.000318	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GNA11—melanoma	0.000318	0.000318	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FLT1—melanoma	0.000317	0.000317	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—VEGFA—melanoma	0.000317	0.000317	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PRKCA—melanoma	0.000315	0.000315	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CG—melanoma	0.000314	0.000314	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—STAT3—melanoma	0.000313	0.000313	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NRAS—melanoma	0.000313	0.000313	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MAP2K2—melanoma	0.000307	0.000307	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—F2R—melanoma	0.000301	0.000301	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MAPK3—melanoma	0.000299	0.000299	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HDAC2—melanoma	0.000299	0.000299	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FOXO4—melanoma	0.000299	0.000299	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCR4—melanoma	0.000299	0.000299	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GNAQ—melanoma	0.000296	0.000296	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—RAC1—melanoma	0.000292	0.000292	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EDNRB—melanoma	0.000291	0.000291	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MYC—melanoma	0.000291	0.000291	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CG—melanoma	0.000285	0.000285	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MAPK1—melanoma	0.000285	0.000285	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EGFR—melanoma	0.000285	0.000285	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTK2B—melanoma	0.000283	0.000283	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SYK—melanoma	0.000278	0.000278	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CD—melanoma	0.000276	0.000276	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GAB2—melanoma	0.000275	0.000275	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNA11—melanoma	0.000275	0.000275	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FLT1—melanoma	0.000274	0.000274	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ITGAV—melanoma	0.000273	0.000273	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT3—melanoma	0.000273	0.000273	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NGFR—melanoma	0.000273	0.000273	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CG—melanoma	0.000271	0.000271	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—KRAS—melanoma	0.000269	0.000269	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FOXO4—melanoma	0.000259	0.000259	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HDAC2—melanoma	0.000259	0.000259	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCR4—melanoma	0.000259	0.000259	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNAQ—melanoma	0.000256	0.000256	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SOCS1—melanoma	0.000253	0.000253	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MAP2K1—melanoma	0.000252	0.000252	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—S100B—melanoma	0.000252	0.000252	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CD—melanoma	0.000251	0.000251	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PIK3CA—melanoma	0.000247	0.000247	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CG—melanoma	0.000246	0.000246	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ERBB4—melanoma	0.000241	0.000241	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CB—melanoma	0.000241	0.000241	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SYK—melanoma	0.00024	0.00024	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TP53—melanoma	0.000239	0.000239	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDKN2B—melanoma	0.000239	0.000239	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CD—melanoma	0.000238	0.000238	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT3—melanoma	0.000236	0.000236	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NGFR—melanoma	0.000236	0.000236	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ITGAV—melanoma	0.000236	0.000236	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CD86—melanoma	0.000231	0.000231	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CXCL8—melanoma	0.000231	0.000231	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EDN1—melanoma	0.00023	0.00023	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HRAS—melanoma	0.000229	0.000229	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGF1—melanoma	0.000224	0.000224	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CSF2—melanoma	0.000224	0.000224	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—IL2—melanoma	0.000221	0.000221	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—E2F1—melanoma	0.00022	0.00022	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL6—melanoma	0.000219	0.000219	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SOCS1—melanoma	0.000219	0.000219	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CB—melanoma	0.000218	0.000218	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MAP2K1—melanoma	0.000218	0.000218	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—S100B—melanoma	0.000218	0.000218	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PDGFRA—melanoma	0.000217	0.000217	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CD—melanoma	0.000217	0.000217	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ITGB3—melanoma	0.000215	0.000215	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRKCA—melanoma	0.000215	0.000215	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SPP1—melanoma	0.000211	0.000211	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAP2K2—melanoma	0.00021	0.00021	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CXCL8—melanoma	0.00021	0.00021	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ERBB4—melanoma	0.000208	0.000208	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CB—melanoma	0.000208	0.000208	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDKN2B—melanoma	0.000207	0.000207	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKT1—melanoma	0.000202	0.000202	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL2—melanoma	0.000201	0.000201	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TERT—melanoma	0.0002	0.0002	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CD86—melanoma	0.0002	0.0002	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CXCL8—melanoma	0.0002	0.0002	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RAC1—melanoma	0.000199	0.000199	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EDN1—melanoma	0.000198	0.000198	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGF1—melanoma	0.000194	0.000194	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CSF2—melanoma	0.000194	0.000194	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HIF1A—melanoma	0.000191	0.000191	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—IL2—melanoma	0.000191	0.000191	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—E2F1—melanoma	0.00019	0.00019	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CB—melanoma	0.000189	0.000189	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PDGFRA—melanoma	0.000188	0.000188	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ITGB3—melanoma	0.000186	0.000186	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRKCA—melanoma	0.000186	0.000186	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KDR—melanoma	0.000183	0.000183	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SPP1—melanoma	0.000182	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAP2K2—melanoma	0.000182	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCL8—melanoma	0.000181	0.000181	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FN1—melanoma	0.000176	0.000176	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL2—melanoma	0.000173	0.000173	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TERT—melanoma	0.000173	0.000173	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOTCH1—melanoma	0.000172	0.000172	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RAC1—melanoma	0.000172	0.000172	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CD80—melanoma	0.000169	0.000169	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CG—melanoma	0.000168	0.000168	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KIT—melanoma	0.000168	0.000168	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APC—melanoma	0.000168	0.000168	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—NRAS—melanoma	0.000168	0.000168	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGF—melanoma	0.000167	0.000167	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HIF1A—melanoma	0.000165	0.000165	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MAPK3—melanoma	0.000161	0.000161	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—BRAF—melanoma	0.000158	0.000158	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KDR—melanoma	0.000158	0.000158	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1—melanoma	0.000154	0.000154	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MAPK1—melanoma	0.000153	0.000153	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EGFR—melanoma	0.000153	0.000153	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FN1—melanoma	0.000152	0.000152	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAP2K1—melanoma	0.000149	0.000149	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOTCH1—melanoma	0.000149	0.000149	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CD—melanoma	0.000148	0.000148	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CA—melanoma	0.000147	0.000147	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CD80—melanoma	0.000146	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KIT—melanoma	0.000146	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CG—melanoma	0.000146	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APC—melanoma	0.000146	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—NRAS—melanoma	0.000146	0.000146	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—KRAS—melanoma	0.000145	0.000145	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGF—melanoma	0.000144	0.000144	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGF2—melanoma	0.000142	0.000142	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MAPK3—melanoma	0.000139	0.000139	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—BRAF—melanoma	0.000137	0.000137	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1—melanoma	0.000133	0.000133	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CA—melanoma	0.000133	0.000133	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MDM2—melanoma	0.000133	0.000133	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MAPK1—melanoma	0.000133	0.000133	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EGFR—melanoma	0.000133	0.000133	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ERBB2—melanoma	0.000131	0.000131	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CB—melanoma	0.000129	0.000129	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAP2K1—melanoma	0.000129	0.000129	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CD—melanoma	0.000128	0.000128	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CA—melanoma	0.000127	0.000127	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—KRAS—melanoma	0.000125	0.000125	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL8—melanoma	0.000124	0.000124	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HRAS—melanoma	0.000123	0.000123	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGF2—melanoma	0.000122	0.000122	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDKN1B—melanoma	0.000121	0.000121	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT1—melanoma	0.00012	0.00012	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CASP3—melanoma	0.000119	0.000119	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL2—melanoma	0.000119	0.000119	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6—melanoma	0.000118	0.000118	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCND1—melanoma	0.000116	0.000116	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CA—melanoma	0.000115	0.000115	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MDM2—melanoma	0.000115	0.000115	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CTNNB1—melanoma	0.000114	0.000114	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ERBB2—melanoma	0.000113	0.000113	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP9—melanoma	0.000112	0.000112	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDKN1A—melanoma	0.000112	0.000112	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTEN—melanoma	0.000112	0.000112	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CB—melanoma	0.000112	0.000112	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NFKB1—melanoma	0.000111	0.000111	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT1—melanoma	0.000109	0.000109	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL8—melanoma	0.000107	0.000107	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HRAS—melanoma	0.000106	0.000106	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDKN1B—melanoma	0.000105	0.000105	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT1—melanoma	0.000104	0.000104	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CASP3—melanoma	0.000103	0.000103	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL2—melanoma	0.000102	0.000102	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6—melanoma	0.000102	0.000102	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFA—melanoma	0.000101	0.000101	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCND1—melanoma	9.98e-05	9.98e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—STAT3—melanoma	9.98e-05	9.98e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NRAS—melanoma	9.95e-05	9.95e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CTNNB1—melanoma	9.89e-05	9.89e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP9—melanoma	9.69e-05	9.69e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDKN1A—melanoma	9.66e-05	9.66e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTEN—melanoma	9.64e-05	9.64e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NFKB1—melanoma	9.59e-05	9.59e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAPK3—melanoma	9.53e-05	9.53e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT1—melanoma	9.4e-05	9.4e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MYC—melanoma	9.27e-05	9.27e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAPK1—melanoma	9.07e-05	9.07e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGFR—melanoma	9.07e-05	9.07e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFA—melanoma	8.7e-05	8.7e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—STAT3—melanoma	8.62e-05	8.62e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NRAS—melanoma	8.6e-05	8.6e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KRAS—melanoma	8.56e-05	8.56e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAPK3—melanoma	8.23e-05	8.23e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MYC—melanoma	8.01e-05	8.01e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CA—melanoma	7.87e-05	7.87e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAPK1—melanoma	7.83e-05	7.83e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGFR—melanoma	7.83e-05	7.83e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TP53—melanoma	7.61e-05	7.61e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KRAS—melanoma	7.4e-05	7.4e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HRAS—melanoma	7.28e-05	7.28e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6—melanoma	6.97e-05	6.97e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CA—melanoma	6.8e-05	6.8e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TP53—melanoma	6.58e-05	6.58e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT1—melanoma	6.43e-05	6.43e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HRAS—melanoma	6.29e-05	6.29e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6—melanoma	6.02e-05	6.02e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT1—melanoma	5.55e-05	5.55e-05	CbGpPWpGaD
